AU3731397A - Methods and compositions for modulation of growth response - Google Patents

Methods and compositions for modulation of growth response

Info

Publication number
AU3731397A
AU3731397A AU37313/97A AU3731397A AU3731397A AU 3731397 A AU3731397 A AU 3731397A AU 37313/97 A AU37313/97 A AU 37313/97A AU 3731397 A AU3731397 A AU 3731397A AU 3731397 A AU3731397 A AU 3731397A
Authority
AU
Australia
Prior art keywords
modulation
compositions
methods
growth response
growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU37313/97A
Inventor
Donald W Kufe
Ralph R Weichselbaum
Zhimin Yuan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arch Development Corp
Original Assignee
Arch Development Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arch Development Corp filed Critical Arch Development Corp
Publication of AU3731397A publication Critical patent/AU3731397A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57496—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving intracellular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU37313/97A 1996-07-18 1997-07-18 Methods and compositions for modulation of growth response Abandoned AU3731397A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2212496P 1996-07-18 1996-07-18
US60022124 1996-07-18
PCT/US1997/012498 WO1998003195A1 (en) 1996-07-18 1997-07-18 Methods and compositions for modulation of growth response

Publications (1)

Publication Number Publication Date
AU3731397A true AU3731397A (en) 1998-02-10

Family

ID=21807939

Family Applications (1)

Application Number Title Priority Date Filing Date
AU37313/97A Abandoned AU3731397A (en) 1996-07-18 1997-07-18 Methods and compositions for modulation of growth response

Country Status (2)

Country Link
AU (1) AU3731397A (en)
WO (1) WO1998003195A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6811788B2 (en) 2000-01-19 2004-11-02 Baofa Yu Combinations and methods for treating neoplasms
US7927612B2 (en) 2000-01-19 2011-04-19 Baofa Yu Combinations and methods for treating neoplasms
US7118862B2 (en) 2001-04-18 2006-10-10 Dana-Farber Cancer Institute, Inc. Induction of apoptosis by cellular stress
CN101138634A (en) 2006-09-07 2008-03-12 于保法 Composition for treating tumour
US11110303B2 (en) 2014-11-26 2021-09-07 Baofa Yu Hapten-enhanced chemoimmunotherapy by ultra-minimum incision personalized intratumoral chemoimmunotherapy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747469A (en) * 1991-03-06 1998-05-05 Board Of Regents, The University Of Texas System Methods and compositions comprising DNA damaging agents and p53
US5658784A (en) * 1994-04-14 1997-08-19 Dana-Farber Cancer Institute, Inc. Nucleic acid encoding transcription factor p300 and uses of p300

Also Published As

Publication number Publication date
WO1998003195A1 (en) 1998-01-29

Similar Documents

Publication Publication Date Title
AU1747497A (en) Soil stabilization composition and method
AU6898996A (en) Compositions and methods for growth promotion
AU5081298A (en) Surgical method and composition therefor
AU5520998A (en) Reduction of hair growth
AU1532297A (en) Starch-emulsifier composition and methods of making
AU1957697A (en) Methods and compositions for the modulation of cell proliferation and wound healing
AU2757097A (en) Method of coating and compositions for use therein
AU3599597A (en) Reduction of hair growth
AU6298894A (en) Compositions and methods for promoting hair growth
AU6485996A (en) Methods and compositions for modulation and inhibition of teomerase
AU5730298A (en) Reduction of hair growth
AU1446300A (en) Method of modulating hair growth
AU2259897A (en) Methods and compositions for the simultaneous control of rootdiseases
AU2165497A (en) Insecticidal composition and method of preparation
AU1903799A (en) Compositions and methods for modulating the activity of fibroblast growth factor
AU2273397A (en) Methods and compositions for modulating an immune response
AU3200197A (en) New composition and methods
AU3731397A (en) Methods and compositions for modulation of growth response
AU1849297A (en) Compositions and methods for enzyme deactivation
AU2556195A (en) CD40 binding compositions and methods of using same
AU1856297A (en) Lyst1 and lyst2 gene compositions and methods of use
AU2221400A (en) Compositions containing and methods of using n-acyl-1h-aminoindenes
AU1377099A (en) Methods and compositions for modulation of bacterial topoisomerase enzymes
AU2823495A (en) Methods and compositions for modulation of wound healing
AU1350699A (en) Compositions and methods for modulating the activity of fibroblast growth factor